oxybutynin has been researched along with Orthomyxoviridae Infections in 5 studies
oxybutynin: RN given refers to parent cpd
oxybutynin : A racemate comprising equimolar amounts of (R)-oxybutynin and esoxybutynin. An antispasmodic used for the treatment of overactive bladder.
Orthomyxoviridae Infections: Virus diseases caused by the ORTHOMYXOVIRIDAE.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Whole inactivated influenza virus vaccine (A/Puerto Rico/8/34) was formulated into dissolving microneedle patches and vaccine stability was evaluated by in vitro and in vivo assays of antigenicity and immunogenicity after storage for up to 3 months at 4, 25, 37 and 45°C." | 1.43 | Enhanced Stability of Inactivated Influenza Vaccine Encapsulated in Dissolving Microneedle Patches. ( Chu, LY; Compans, RW; Dong, K; Prausnitz, MR; Yang, C; Ye, L, 2016) |
| "Prevention of seasonal influenza epidemics and pandemics relies on widespread vaccination coverage to induce protective immunity." | 1.42 | Improved immunogenicity of individual influenza vaccine components delivered with a novel dissolving microneedle patch stable at room temperature. ( Compans, RW; Esser, ES; Kalluri, H; McAllister, D; Pewin, WP; Prausnitz, MR; Pulit-Penaloza, JA; Skountzou, I; Taherbhai, MT; Vassilieva, EV, 2015) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (80.00) | 24.3611 |
| 2020's | 1 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Vassilieva, EV | 3 |
| Li, S | 1 |
| Korniychuk, H | 1 |
| Taylor, DM | 1 |
| Wang, S | 1 |
| Prausnitz, MR | 4 |
| Compans, RW | 4 |
| Littauer, EQ | 1 |
| Mills, LK | 1 |
| Brock, N | 1 |
| Esser, ES | 2 |
| Romanyuk, A | 1 |
| Pulit-Penaloza, JA | 2 |
| Beaver, JT | 1 |
| Antao, O | 1 |
| Krammer, F | 1 |
| Skountzou, I | 2 |
| Kalluri, H | 1 |
| McAllister, D | 1 |
| Taherbhai, MT | 1 |
| Pewin, WP | 1 |
| Chu, LY | 1 |
| Ye, L | 1 |
| Dong, K | 1 |
| Yang, C | 1 |
| Kommareddy, S | 1 |
| Baudner, BC | 1 |
| Bonificio, A | 1 |
| Gallorini, S | 1 |
| Palladino, G | 1 |
| Determan, AS | 1 |
| Dohmeier, DM | 1 |
| Kroells, KD | 1 |
| Sternjohn, JR | 1 |
| Singh, M | 1 |
| Dormitzer, PR | 1 |
| Hansen, KJ | 1 |
| O'Hagan, DT | 1 |
5 other studies available for oxybutynin and Orthomyxoviridae Infections
| Article | Year |
|---|---|
cGAMP/Saponin Adjuvant Combination Improves Protective Response to Influenza Vaccination by Microneedle Patch in an Aged Mouse Model.
Topics: Adjuvants, Immunologic; Aging; Animals; Disease Models, Animal; Drug Delivery Systems; Female; Human | 2020 |
Stable incorporation of GM-CSF into dissolvable microneedle patch improves skin vaccination against influenza.
Topics: Administration, Cutaneous; Animals; Dogs; Female; Granulocyte-Macrophage Colony-Stimulating Factor; | 2018 |
Improved immunogenicity of individual influenza vaccine components delivered with a novel dissolving microneedle patch stable at room temperature.
Topics: Animals; Antigens, Viral; Drug Delivery Systems; Drug Stability; Female; Humans; Immunity, Humoral; | 2015 |
Enhanced Stability of Inactivated Influenza Vaccine Encapsulated in Dissolving Microneedle Patches.
Topics: Animals; Drug Delivery Systems; Drug Storage; Hot Temperature; Humans; Immunization; Influenza A Vir | 2016 |
Influenza subunit vaccine coated microneedle patches elicit comparable immune responses to intramuscular injection in guinea pigs.
Topics: Administration, Cutaneous; Animals; Antibodies, Viral; Antigens, Viral; Drug Stability; Female; Guin | 2013 |